Liquid alternatives specialist Balter Capital Management launched an all-capitalization long/short equity mutual fund in partnership with Invenomic Capital Management. The Balter Invenomic Fund (BIVIX) will have its operations and compliance managed out of the Balter Liquid Alternatives unit, with Invenomic acting as sub-adviser. The fund will utilize quantitative analysis on the front end along with fundamental analysis on the back end to invest in both large and small companies, predominately in the U.S.
Link To Article

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.